Product Code: ETC6184456 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Magnetic particle imaging (MPI) is an emerging non-invasive imaging technology offering high sensitivity and zero background noise, making it highly effective for tracking magnetic nanoparticles in the body. In Australia, the MPI market is in its nascent stage but gaining traction due to growing interest in advanced diagnostic imaging. This technique holds promise for applications in cancer detection, cardiovascular diagnostics, and stem cell tracking. Research institutions and healthcare technology firms in Australia are exploring the integration of MPI into clinical settings, supported by increasing investment in medical imaging innovation. Its potential to complement or even surpass traditional imaging modalities like MRI and CT in certain applications could lead to rapid market growth. With the ongoing development of targeted contrast agents, MPI is poised to revolutionize medical diagnostics.
Magnetic particle imaging (MPI) is an emerging modality in Australias medical diagnostics landscape, offering high-resolution imaging without ionizing radiation. Its potential use in cardiovascular and cancer imaging has sparked interest among research institutions and healthcare providers. While not yet mainstream, early trials and academic studies are paving the way for commercial adoption. Investment in advanced diagnostic technologies and growing demand for non-invasive imaging solutions are favorable conditions for MPI market growth. As awareness of its clinical benefits increases, the market is likely to expand within academic hospitals and private diagnostic centers.
The magnetic particle imaging (MPI) market in Australia faces slow adoption primarily due to the high cost of equipment and installation. Limited clinical trials and validation studies in Australia reduce physician confidence in embracing MPI over existing imaging modalities like MRI and CT scans. Research funding in niche imaging technologies remains low, restricting innovation and domestic development. Access to trained radiologists and technicians familiar with MPI systems is limited. Furthermore, hospital procurement cycles for expensive imaging technologies are lengthy and bureaucratic. Regulatory hurdles for medical devices are stringent, increasing time-to-market for new MPI equipment.
Magnetic particle imaging (MPI) is a new imaging technology that provides high-resolution, real-time imaging with minimal radiation exposure, making it a promising option for medical diagnostics. The MPI market in Australia is emerging as healthcare providers look for advanced imaging systems for applications in oncology, cardiology, and neurology. Investment opportunities in this market lie in the development of MPI machines, improving imaging sensitivity, and expanding their applications for clinical diagnostics. As healthcare providers continue to seek non-invasive, high-precision diagnostic tools, MPI is poised to become a significant part of the medical imaging landscape in Australia, particularly in research-driven hospitals and specialized clinics.
Magnetic Particle Imaging (MPI) is an emerging medical imaging technique, and its regulation in Australia is managed by the Therapeutic Goods Administration (TGA). As with all medical devices, MPI systems must undergo thorough safety and efficacy evaluations before market approval. The federal government encourages innovation in medical technology through research grants and collaboration with universities and hospitals. While MPI is not yet widespread in Australian hospitals, ongoing funding in advanced imaging could facilitate its adoption. If clinically proven, the technology could be integrated into public health infrastructure under Medicare schemes. Continued investment in medical R&D is a policy priority in national health strategy plans.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Magnetic Particle Imaging Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Magnetic Particle Imaging Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Magnetic Particle Imaging Market - Industry Life Cycle |
3.4 Australia Magnetic Particle Imaging Market - Porter's Five Forces |
3.5 Australia Magnetic Particle Imaging Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Magnetic Particle Imaging Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.7 Australia Magnetic Particle Imaging Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Australia Magnetic Particle Imaging Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Australia Magnetic Particle Imaging Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Magnetic Particle Imaging Market Trends |
6 Australia Magnetic Particle Imaging Market, By Types |
6.1 Australia Magnetic Particle Imaging Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Magnetic Particle Imaging Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Magnetic Particle Imaging Market Revenues & Volume, By Tracer, 2021- 2031F |
6.1.4 Australia Magnetic Particle Imaging Market Revenues & Volume, By MPI Scanner, 2021- 2031F |
6.2 Australia Magnetic Particle Imaging Market, By Modality |
6.2.1 Overview and Analysis |
6.2.2 Australia Magnetic Particle Imaging Market Revenues & Volume, By Magnetic Resonance Imaging, 2021- 2031F |
6.2.3 Australia Magnetic Particle Imaging Market Revenues & Volume, By Positron Emission Tomography, 2021- 2031F |
6.3 Australia Magnetic Particle Imaging Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Australia Magnetic Particle Imaging Market Revenues & Volume, By Vascular Imaging, 2021- 2031F |
6.3.3 Australia Magnetic Particle Imaging Market Revenues & Volume, By Perfusion Imaging, 2021- 2031F |
6.3.4 Australia Magnetic Particle Imaging Market Revenues & Volume, By Blood Pool Imaging, 2021- 2031F |
6.3.5 Australia Magnetic Particle Imaging Market Revenues & Volume, By Neuroimaging, 2021- 2031F |
6.3.6 Australia Magnetic Particle Imaging Market Revenues & Volume, By Localized Hyperthermia, 2021- 2031F |
6.3.7 Australia Magnetic Particle Imaging Market Revenues & Volume, By Oncology Imaging, 2021- 2031F |
6.3.8 Australia Magnetic Particle Imaging Market Revenues & Volume, By Inflammation Imaging, 2021- 2031F |
6.3.9 Australia Magnetic Particle Imaging Market Revenues & Volume, By Inflammation Imaging, 2021- 2031F |
6.4 Australia Magnetic Particle Imaging Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Australia Magnetic Particle Imaging Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Australia Magnetic Particle Imaging Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 Australia Magnetic Particle Imaging Market Import-Export Trade Statistics |
7.1 Australia Magnetic Particle Imaging Market Export to Major Countries |
7.2 Australia Magnetic Particle Imaging Market Imports from Major Countries |
8 Australia Magnetic Particle Imaging Market Key Performance Indicators |
9 Australia Magnetic Particle Imaging Market - Opportunity Assessment |
9.1 Australia Magnetic Particle Imaging Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Magnetic Particle Imaging Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.3 Australia Magnetic Particle Imaging Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Australia Magnetic Particle Imaging Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Australia Magnetic Particle Imaging Market - Competitive Landscape |
10.1 Australia Magnetic Particle Imaging Market Revenue Share, By Companies, 2024 |
10.2 Australia Magnetic Particle Imaging Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |